Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Functional Pdgfra fibroblast heterogeneity in normal and fibrotic mouse lung
Carol S. Trempus, … , Anne K. Perl, Stavros Garantziotis
Carol S. Trempus, … , Anne K. Perl, Stavros Garantziotis
Published October 12, 2023
Citation Information: JCI Insight. 2023;8(22):e164380. https://doi.org/10.1172/jci.insight.164380.
View: Text | PDF
Research Article Pulmonology

Functional Pdgfra fibroblast heterogeneity in normal and fibrotic mouse lung

  • Text
  • PDF
Abstract

Aberrant fibroblast function plays a key role in the pathogenesis of idiopathic pulmonary fibrosis, a devastating disease of unrelenting extracellular matrix deposition in response to lung injury. Platelet-derived growth factor α–positive (Pdgfra+) lipofibroblasts (LipoFBs) are essential for lung injury response and maintenance of a functional alveolar stem cell niche. Little is known about the effects of lung injury on LipoFB function. Here, we used single-cell RNA-Seq (scRNA-Seq) technology and PdgfraGFP lineage tracing to generate a transcriptomic profile of Pdgfra+ fibroblasts in normal and injured mouse lungs 14 days after bleomycin exposure, generating 11 unique transcriptomic clusters that segregated according to treatment. While normal and injured LipoFBs shared a common gene signature, injured LipoFBs acquired fibrogenic pathway activity with an attenuation of lipogenic pathways. In a 3D organoid model, injured Pdgfra+ fibroblast–supported organoids were morphologically distinct from those cultured with normal fibroblasts, and scRNA-Seq analysis suggested distinct transcriptomic changes in alveolar epithelia supported by injured Pdgfra+ fibroblasts. In summary, while LipoFBs in injured lung have not migrated from their niche and retain their lipogenic identity, they acquire a potentially reversible fibrogenic profile, which may alter the kinetics of epithelial regeneration and potentially contribute to dysregulated repair, leading to fibrosis.

Authors

Carol S. Trempus, Brian N. Papas, Maria I. Sifre, Carl D. Bortner, Erica Scappini, Charles J. Tucker, Xin Xu, Katina L. Johnson, Leesa J. Deterding, Jason G. Williams, Dylan J. Johnson, Jian-Liang Li, Deloris Sutton, Charan Ganta, Debabrata Mahapatra, Muhammad Arif, Abhishek Basu, Lenny Pommerolle, Resat Cinar, Anne K. Perl, Stavros Garantziotis

×

Figure 6

Fibroblast subpopulations in normal and fibrotic lungs of humans and mice revealed by scRNA-Seq analyses.

Options: View larger image (or click on image) Download as PowerPoint
Fibroblast subpopulations in normal and fibrotic lungs of humans and mic...
(A) Fibroblast populations in 4 bleomycin-induced and 4 saline control lung tissues on day 11 from GEO GSE129605. (B) Fibroblast populations on day 14: scRNA-Seq fibrosis and wild-type control data from 2 Col1a1GFP reporter mice treated with bleomycin (GEO GSE132771). (C) Fibroblast populations in human lung tissue: scRNA-Seq data from 8 normal lung transplant donors and 4 IPF patients (GEO GSE122960). (D) Fibroblast populations in human scRNA-Seq lung data from 3 normal individuals and 3 IPF patients (GEO GSE132771). For panels A–D, the dot plots display the expression patterns of fibroblast subtypes using top markers from Figure 1D. (E–H) The same data sets (A–D, respectively) queried with the shared LipoFB gene from Figure 3. IPF, idiopathic pulmonary fibrosis; MatrixFB, matrix fibroblast; LipoFB, lipofibroblast; MyoFB, myofibroblast; PMP, proliferating mesenchymal progenitors; ME, mesothelial cell.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts